Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated:  5/26/2015
University of Wisconsin Hospital and Clinics
929
mi
from 02139
Madison, WI
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated: 5/26/2015
University of Wisconsin Hospital and Clinics
929
mi
from 02139
Madison, WI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
2283
mi
from 02139
Scottsdale, AZ
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
2283
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
2566
mi
from 02139
Oceanside, CA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
2566
mi
from 02139
Oceanside, CA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
2690
mi
from 02139
San Francisco, CA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
2690
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
114
mi
from 02139
Hamden, CT
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
114
mi
from 02139
Hamden, CT
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
90
mi
from 02139
Hartford, CT
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
90
mi
from 02139
Hartford, CT
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1076
mi
from 02139
Gainesville, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1076
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1256
mi
from 02139
Miami, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1256
mi
from 02139
Miami, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1110
mi
from 02139
Winter Park, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1110
mi
from 02139
Winter Park, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
934
mi
from 02139
Atlanta, GA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
934
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
741
mi
from 02139
Crestview Hills, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
741
mi
from 02139
Crestview Hills, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
766
mi
from 02139
Lexington, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
766
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
821
mi
from 02139
Louisville, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
357
mi
from 02139
Baltimore, MD
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
2
mi
from 02139
Boston, MA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
2
mi
from 02139
Boston, MA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
643
mi
from 02139
Ann Arbor, MI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1128
mi
from 02139
Plymouth, MN
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1128
mi
from 02139
Plymouth, MN
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1132
mi
from 02139
Columbia, MO
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1132
mi
from 02139
Columbia, MO
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
105
mi
from 02139
Lebanon, NH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
105
mi
from 02139
Lebanon, NH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
173
mi
from 02139
Lake Success, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
173
mi
from 02139
Lake Success, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
180
mi
from 02139
New York, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
180
mi
from 02139
New York, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
334
mi
from 02139
Rochester, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
334
mi
from 02139
Rochester, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
132
mi
from 02139
Troy, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
132
mi
from 02139
Troy, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
616
mi
from 02139
Chapel Hill, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
616
mi
from 02139
Chapel Hill, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
719
mi
from 02139
Charlotte, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
719
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
608
mi
from 02139
Raleigh, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
608
mi
from 02139
Raleigh, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
735
mi
from 02139
Cincinnati, OH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
547
mi
from 02139
Cleveland, OH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
547
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
40
mi
from 02139
Providence, RI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
40
mi
from 02139
Providence, RI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
40
mi
from 02139
Providence, RI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
40
mi
from 02139
Providence, RI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
939
mi
from 02139
Nashville, TN
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
939
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1554
mi
from 02139
Grapevine, TX
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1554
mi
from 02139
Grapevine, TX
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
1601
mi
from 02139
Houston, TX
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
2493
mi
from 02139
Tacoma, WA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
2493
mi
from 02139
Tacoma, WA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
279
mi
from 02139
Egg Harbour Township, NJ
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
279
mi
from 02139
Egg Harbour Township, NJ
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
173
mi
from 02139
Great Neck, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
173
mi
from 02139
Great Neck, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Research site
1678
mi
from 02139
San Juan,
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Research site
1678
mi
from 02139
San Juan,
Click here to add this to my saved trials
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Molecular Imaging to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Status: Enrolling
Updated:  7/20/2015
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Molecular Imaging to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Status: Enrolling
Updated: 7/20/2015
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  7/28/2015
Jackson Memorial Hospital
1256
mi
from 02139
Miami, FL
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 7/28/2015
Jackson Memorial Hospital
1256
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Ultrasound Stiffness Imaging in Crohn's Disease
Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease
Status: Enrolling
Updated:  7/29/2015
University of Michigan Health System
643
mi
from 02139
Ann Arbor, MI
Ultrasound Stiffness Imaging in Crohn's Disease
Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease
Status: Enrolling
Updated: 7/29/2015
University of Michigan Health System
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Status: Enrolling
Updated:  8/7/2015
Indiana University
804
mi
from 02139
Indianapolis, IN
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Status: Enrolling
Updated: 8/7/2015
Indiana University
804
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
OPERA Database - Crohn's Protocol
IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol
Status: Enrolling
Updated:  8/14/2015
Dartmouth Hitchcock Medical Center
105
mi
from 02139
Lebanon, NH
OPERA Database - Crohn's Protocol
IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol
Status: Enrolling
Updated: 8/14/2015
Dartmouth Hitchcock Medical Center
105
mi
from 02139
Lebanon, NH
Click here to add this to my saved trials
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Status: Enrolling
Updated:  8/21/2015
Children's Hospital of Wisconsin
859
mi
from 02139
Milwaukee, WI
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Status: Enrolling
Updated: 8/21/2015
Children's Hospital of Wisconsin
859
mi
from 02139
Milwaukee, WI
Click here to add this to my saved trials
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
A Prospective Trial of Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Status: Enrolling
Updated:  9/16/2015
Univ of Rochester Medical Center
335
mi
from 02139
Rochester, NY
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
A Prospective Trial of Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Status: Enrolling
Updated: 9/16/2015
Univ of Rochester Medical Center
335
mi
from 02139
Rochester, NY
Click here to add this to my saved trials
Immune Ablation and Stem Cell Support for Crohn's Disease
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
Status: Enrolling
Updated:  9/21/2015
Children's Memorial Hospital
847
mi
from 02139
Chicago, IL
Immune Ablation and Stem Cell Support for Crohn's Disease
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
Status: Enrolling
Updated: 9/21/2015
Children's Memorial Hospital
847
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Southern California Medical Gastroenterology Group
2602
mi
from 02139
Santa Monica, CA
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Southern California Medical Gastroenterology Group
2602
mi
from 02139
Santa Monica, CA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Gastroenterology Research of New Orleans
1348
mi
from 02139
Hammond, LA
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Gastroenterology Research of New Orleans
1348
mi
from 02139
Hammond, LA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
390
mi
from 02139
Chevy Chase, MD
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
390
mi
from 02139
Chevy Chase, MD
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Nyu Langone Long Island Clinical Research Associates
173
mi
from 02139
Great Neck, NY
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Nyu Langone Long Island Clinical Research Associates
173
mi
from 02139
Great Neck, NY
Click here to add this to my saved trials